CATESTATIN AS A NOVEL MARKER OF CARDIOVASCULAR RISK IN SYSTEMIC HYPERTENSION

CATESTATIN AS A NOVEL MARKER OF CARDIOVASCULAR RISK IN SYSTEMIC HYPERTENSION

Review of the key studies on antihypertensive, vasodilatatory, angiogenic and antiapoptotic action of catestatin — a peptide resulting from endogenic protease interaction with chromogranin А. Plasma levels of catestatin correlate negatively with the hypertension phenotype. Pathogenetic role is discu...

Full description

Bibliographic Details
Main Authors: E. Yu. Gubareva, N. N. Kryukov, I. V. Gubareva
Format: Article
Language:Russian
Published: «FIRMA «SILICEA» LLC  2018-05-01
Series:Российский кардиологический журнал
Subjects:
catestatin
essential hypertension
cardiovascular risk
Online Access:https://russjcardiol.elpub.ru/jour/article/view/2656
Description
Summary:Review of the key studies on antihypertensive, vasodilatatory, angiogenic and antiapoptotic action of catestatin — a peptide resulting from endogenic protease interaction with chromogranin А. Plasma levels of catestatin correlate negatively with the hypertension phenotype. Pathogenetic role is discussed for catestatin in development of essential hypertension and its possible influence as a marker of cardiovascular risk stratification.
ISSN:1560-4071
2618-7620

Similar Items